期刊文献+

皮肌炎57例临床分析

Clinical analysis of 57 patients with dermatomyositis
下载PDF
导出
摘要 目的探讨皮肌炎(DM)的临床特点、诊断及治疗。方法按照世界卫生组织(WHO)对皮肌炎的诊断标准,对57例DM患者资料进行回顾性分析。结果DM以女性多见,多以皮损为首发症状,部分合并其它系统的损害,少数合并恶性肿瘤、重叠综合征、丙型肝炎病毒感染。肌酶活性早期多升高,病情好转后下降。本组肌电图的检出率为80%,肌肉活检的检出率为100%,皮肤活检的检出率为80%;激素治疗的有效率为94.74%。结论DM是一组以皮肤损害和肌无力为主要表现的自身免疫性疾病。本病的诊断应结合临床资料、肌酶、肌电图、抗Jol抗体等,皮肤肌肉活检可以确诊。治疗以激素为主。 Objective To explore clinical characters, diagnosis and therapy of dermatomyositis (DM). Methods According to the diagnostic criteria to DM of WHO,medical records of 57 patients with DM were reviewed retrospectively. Results Women were more frequently affected than men. Skin lesion was the initial complaint in most cases. Other systems were involved in some cases. Minority cases showed malignant tumors,overlap syndrome and chronic HCV hepatitis infections. Elevated serum creatine kinase levels were found in 77.19% patients. CK levels decreased when the manifestation improved. 80 % electromyography in 10 patients Were abnormal. The prominent feature was myogenic lesions. The abnormal opportunity of muscular biopsy is 100% in the group, and that of skin biopsy is 80% ,the efficiency of corticosteroid therapy is 97.74%. Conclusion DM is a kind of autoimmune disease which main characters are skin lesion and muscle weakness. Clinical information,serum creatine kinase levels,together with EMG and anti-Jo1 antibody can make diagnosis. Skin and muscular biopsy are strongly recommended if condition permits. Conventional corticosteroid is effective for DM.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2005年第4期359-361,共3页 Journal of Apoplexy and Nervous Diseases
关键词 皮肌炎 抗J01抗体 dermatomyositis(DM) anti-Jo1 antibody
  • 相关文献

参考文献8

  • 1Marie I, Dominique S, Remy-Jardin M,et al. Interstitial lung disease[J]. Rev Med Interne,2001,22(11):1083-1096.
  • 2Yen TH, Lai PC, Chen CC, et al. Renal involvement in patients with polymyositis and dermatomyositis [J]. Int J Clin Pract,2005,59 (2): 188-193.
  • 3Takeda S. Systemic sclerosis(scleroderma) and malignancy[J].Nihon Rinsho Meneki Gakkai Kaishi, 2004,27 (6): 389-396.
  • 4Fiore G,Giacovazzo F,Giacovazzo M. HCV and dermatomyositis:reports of 5 cases of dermatomyositis in patients with HCV infection[J]. Riv Eur Sci Med-Farmacol, 1996,18:197-201.
  • 5Kee KM,Wang JH, Lee CM,et al. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma[J]. Chang Gung Med J, 2004,27 (11 ): 834-839.
  • 6王敏,贾建平,笪宇威.血管因素在多发性肌炎发病机制中的作用[J].中华神经科杂志,2005,38(6):385-388. 被引量:4
  • 7Tanimoto K, Nakano K, Kano S, et al. Classification criteria for polymyositis and dermatomyositis[J]. J Rheumatol, 1995,22 (4):668-674.
  • 8MauriceVictor.Adams and victor''s principles of neurology[J].人民卫生出版社,2002.1497-1500.

二级参考文献14

  • 1Dalakas MC.Immunopathogenesis of inflammatory myopathies.Ann Neurol, 1995, 37 Suppl 1:74-86.
  • 2Schubert W, Kontozis L, Sticker G, et al.Immunofluorescent evidence for presence of interleukin-1 in normal and diseased human skeletal muscle.Muscle Nerve, 1988, 11:890-892.
  • 3Lundberg I, Brengman J, Engel A.Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls.J Neuroimmunol, 1995, 63:9-16.
  • 4Bohan A, Peter JB.Polymyositis and dermatomyositis(second of two parts).N Engl Med, 1975, 292:403-407.
  • 5Nyberg P, Wikman A, Nennesmo I, et al.Increased expression of interleukin 1α and MHC class Ⅰin muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.J Rheumatol, 2000, 27:940-948.
  • 6De Letter MA, van Doorn PA, Savelkoul HF, et al.Critical illness polyneuropathy and myopathy(CIPNM):evidence for local immune activation by cytokine-expression in the muscle tissue.J Neuroimmunol, 2000, 106:206-213.
  • 7Ito T, Kumamoto T, Horinouchi H, et al.Adhesion molecule expression in experimental myositis.Muscle Nerve, 2002, 25:409-418.
  • 8Englund P, Nennesmo I, Klareskog L, et al.Interleukin-1α expression in capillaries and major histocompatibility complex class Ⅰexpression in type Ⅱ muscle fibers from polymyositis and dermatomyositis patients :important pathogenic features independent of inflammatory cell clusters in muscle tissue.Arthritis Rheum, 2002, 46:1044-1055.
  • 9Lundberg I, Nyberg P.New developments in the role of cytokines and chemokines in inflammatory myopathies.Curr Opin Rheumatol, 1998, 10:521-529.
  • 10Mantovani A, Bussolino F, Inrona M.Cytokine regulation of endothelial cell function:from molecular level to the bedside.Immunol Today, 1997, 18:231-240.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部